Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...

Novo Nordisk is testing its weight-loss drug Ozempic in global Alzheimer's trials to see if it can slow or prevent cognitive ...

GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially ...

GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually ...

A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives ...

Morgan Stanley has downgraded Novo Nordisk, whose U.S. shares are already down a third this year. That downgrade forecasts ...

Incentivizing innovation requires the protection of intellectual property rights. Allowing compounded pharmacies to sell unauthorized versions undermines these rights.

After his dad was diagnosed with Alzheimer's, a 41-year-old CEO changed his habits for better brain health, from doing more cardio to following the MIND diet.